دورية أكاديمية

Activity and safety of lenalidomide and dexamethasone in patients with multiple myeloma requiring dialysis: a Spanish multicenter retrospective study.

التفاصيل البيبلوغرافية
العنوان: Activity and safety of lenalidomide and dexamethasone in patients with multiple myeloma requiring dialysis: a Spanish multicenter retrospective study.
المؤلفون: de la Rubia, Javier1,2, Roig, Mónica1, Ibáñez, Ángela3, García, Inmaculada4, Vera, José A.5, Aguilar, Carlos6, del Campo, Raquel7, González, Nicolás8, Martínez, Rafael9, Palomera, Luis10, Picón, Isabel11, Rodríguez, Juan N.12, Sanz, Miguel A.1
المصدر: European Journal of Haematology. Oct2010, Vol. 85 Issue 4, p363-365. 3p. 2 Charts.
مصطلحات موضوعية: *MULTIPLE myeloma treatment, *IMMUNOLOGICAL adjuvants, *DRUG efficacy, *HEMODIALYSIS patients, *MEDICAL research
مصطلحات جغرافية: SPAIN
مستخلص: The article reports on a study which examines the efficacy of immunomodulating agent lenalidomide in the management of patients with multiple myeloma (MM) requiring dialysis in Spain. A total of 15 patients with MM and severe renal impairment requiring dialysis and receiving lenalidomide-based therapy were the subject of the study. Findings of the study revealed that lenalidomide-based therapy is associated with a high response rate and a long duration of response.
قاعدة البيانات: Academic Search Index
الوصف
تدمد:09024441
DOI:10.1111/j.1600-0609.2010.01500.x